Action of glucagon-like peptide 1 and glucose levels on corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells

Molecular and Cellular Endocrinology

Volumn 362, Issue 1-2, 2012, Pages 221-226

  Kageyama, Kazunori ^a   Yamagata, Satoshi ^a   Akimoto, Kanako ^a   Sugiyama, Aya ^a   Murasawa, Shingo ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Corticotropin releasing factor; Glucagon like peptide 1; Glucose; Hypothalamus; Stress; Vasopressin

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; CULTURE MEDIUM; FETUS; GENE EXPRESSION REGULATION; HORMONE ACTION; HYPEROSMOLALITY; HYPOTHALAMUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; PITUITARY-ADRENAL SYSTEM; PROMOTER REGIONS, GENETIC; RATS; RECEPTORS, GLUCAGON; VASOPRESSINS;

EID: 84865308656     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.06.023     Document Type: Article

References (31)

1. Antoni F.A. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev. 1986, 7:351-378.
2. Asaba K., Iwasaki Y., Asai M., Yoshida M., Nigawara T., Kambayashi M., Hashimoto K. High glucose activates pituitary proopiomelanocortin gene expression: possible role of free radical-sensitive transcription factors. Diabetes Metab. Res. Rev. 2007, 23:317-323.
3. Bojanowska E., Stempniak B. Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat. Regul. Pept. 2000, 91:75-81.
4. Burbach J.P., Luckman S.M., Murphy D., Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol. Rev. 2001, 81:1197-1267.
5. Drucker D.J., Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006, 368:1696-1705.
6. Gillies G.E., Linton E.A., Lowry P.J. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 1982, 299:355-357.
7. Gonzalez-Hernandez T., Afonso-Oramas D., Cruz-Muros I., Barroso-Chinea P., Abreu P., del Mar Perez-Delgado M., Rancel-Torres N., del Carmen Gonzalez M. Interleukin-6 and nitric oxide synthase expression in the vasopressin and corticotrophin-releasing factor systems of the rat hypothalamus. J. Histochem. Cytochem. 2006, 54:427-441.
8. Heller R.S., Kieffer T.J., Habener J.F. Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes 1997, 46:785-791.
9. Holst J.J. The physiology of glucagon- like peptide 1. Physiol. Rev. 2007, 87:1409-1439.
10. Imeryüz N., Yeĝen B.C., Bozkurt A., Coşkun T., Villanueva-Peñacarrillo M.L., Ulusoy N.B. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am. J. Physiol. 1997, 273:G920-G927.
11. Itoi K., Helmreich D.L., Lopez-Figueroa M.O., Watson S.J. Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine. J. Neurosci. 1999, 19:5464-5472.
12. Itoi K., Jiang Y.Q., Iwasaki Y., Watson S.J. Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus. J. Neuroendocrinol. 2004, 16:348-355.
13. Kageyama K., Hanada K., Iwasaki Y., Sakihara S., Nigawara T., Kasckow J., Suda T. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin, and interleukin-6 gene transcription in hypothalamic 4B cells. J. Endocrinol. 2007, 195:199-211.
14. Kasckow J., Mulchahey J.J., Aguilera G., Pisarska M., Nikodemova M., Chen H.C., Herman J.P., Murphy E.K., Liu Y., Rizvi T.A., Dautzenberg F.M., Sheriff S. Corticotropin-releasing hormone (CRH) expression and protein kinase A mediated CRH receptor signalling in an immortalized hypothalamic cell line. J. Neuroendocrinol. 2003, 15:521-529.
15. Kastin A.J., Akerstrom V., Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J. Mol. Neurosci. 2002, 18:7-14.
16. Kieffer T.J., Habener J.F. The glucagon-like peptides. Endocr. Rev. 1999, 20:876-913.
17. Kinzig K.P., D'Alessio D.A., Seeley R.J. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J. Neurosci. 2002, 22:10470-10476.
18. Kinzig K.P., D'Alessio D.A., Herman J.P., Sakai R.R., Vahl T.P., Figueiredo H.F., Murphy E.K., Seeley R.J. CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors. J. Neurosci. 2003, 23:6163-6170.
19. Kreymann B., Ghatei M.A., Burnet P., Williams G., Kanse S., Diani A.R., Bloom S.R. Characterization of glucagon-like peptide-1-(7-36) amide in the hypothalamus. Brain Res. 1989, 502:325-331.
20. Larsen P.J., Tang-Christensen M., Jessop D.S. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 1997, 138:4445-4455.
21. Liu Y., Kamitakahara A., Kim A.J., Aguilera G. Cyclic adenosine 3',5'-monophosphate responsive element binding protein phosphorylation is required but not sufficient for activation of corticotropin-releasing hormone transcription. Endocrinology 2008, 149:3512-3520.
22. 1 receptor) mRNA via protein kinase A and mitogen-activated protein kinase pathways in rat anterior pituitary cells. Mol. Cell. Endocrinol 2005, 243:74-79.
23. Mouri T., Itoi K., Takahashi K., Suda T., Murakami O., Yoshinaga K., Andoh N., Ohtani H., Masuda T., Sasano N. Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus. Neuroendocrinology 1993, 57:34-39.
24. Sarkar S., Fekete C., Légrádi G., Lechan R.M. Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Brain Res. 2003, 985:163-168.
25. Shughrue P.J., Lane M.V., Merchenthaler I. Glucagon- like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology 1996, 137:5159-5162.
26. Tauchi M., Zhang R., D'Alessio D.A., Stern J.E., Herman J.P. Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei. J. Chem. Neuroanat. 2008, 36:144-149.
27. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M., Meeran K., Choi S.J., Taylor G.M., Heath M.M., Lambert P.D., Wilding J.P., Smith D.M., Ghatei M.A., Herbert J., Bloom S.R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996, 379:69-72.
28. Vale W., Vaughan J., Perrin M.H. Corticotropin-releasing factor (CRF) family ligands and their receptors. Endocrinologist 1997, 7:3S-9S.
29. Vandesande F., Dierickx K., De Mey J. The origin of the vasopressinergic and oxytocinergic fibres of the external region of the median eminence of the rat hypophysis. Cell Tissue Res. 1997, 180:443-452.
30. Whitnall M.H. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog. Neurobiol. 1993, 40:573-629.
31. Wynn P.C., Harwood J.P., Catt K.J., Aguilera G. Regulation of corticotropin-releasing factor (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses. Endocrinology 1985, 116:1653-1659.